State and Federal Developments

Resources that reflect developments regarding federal and state responses to the opioid epidemic.

• Pharmacist Scope of Practice: Prescribing Medications for Opioid Use Disorder (State-Specific Map) (APhA)
• Overview of Pharmacists’ Prescriptive Authority of Controlled Substances
• Pharmacist Controlled Substance Authority by State
• X-Waiver Requirement Removal FAQ (SAMHSA)
• Opioid Analgesic REMS 
  • REMS Compliant Continuing Education
  • Opioid Analgesic REMS Patient Counseling Guide 
  • Medication Guides 
• National Prescription Drug Take Back Day event (DEA)
• National Prescription Drug Take Back Day (DEA)
• Reducing Opioid Misuse Letter to Providers (CMS) 
• 2019 Medicare Part D Opioid Policies: Information for Pharmacies (Tip Sheet) (a webinar is also available) (CMS)   
• Opioid Prescribing by Specialty and Volume in the U.S. (CDC) 
• Surgeon General's Spotlight on Opioids: Facing Addiction in America
• Help, Resources and Information, National Opioid Crisis (HHS) 
  • 5-Point Strategy to Combat the Opioid Crisis 
• HEAL Initiative Research Plan (NIH)
• Surgeon General's Advisory on Naloxone and Opioid Overdose (April 2018)
• DEA 360 Strategy
• Opioids (Agency for Health Research and Quality) 
• White House: The Opioid Crisis
• Naloxone Access in Community Pharmacies (National Alliance of State Pharmacy Associations)
• The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America (November 2016)
• National Pain Strategy (HHS)
• Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws (SAMHSA)
• National and state treatment need and capacity for opioid antagonist medication-assisted treatment
• Fact Sheet – FDA Opioids Action Plan
• Prescription Drug Time and Dosage Limit Laws (CDC)
• The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse (CMS)
• State Laws on Prescription Drug Abuse and Misuse (CDC)